Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Emphasis of FAS/FASL gene polymorphism in patients with non-muscle invasive bladder cancer.

Irish journal of medical science - 1 Nov 2018

Ceylan Cavit, Yahşi Sedat, Doğan Serkan, ÖztÜrk Elife, Ceylan Gulay

Abstract excerpt

BACKGROUND: Bladder cancer (BCa) is the seventh most common cancer among males worldwide. Some reliable markers in blood, urine, and tumor tissue, including clinicopathologic variables, molecular and inflammatory markers, gene polymorphisms, and tumor gene expression profiles are identified for predicting response to BCG immunotherapy in high-risk BCa patients. AIMS: We aimed to determine if FAS and FASL...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BCG Vaccine
Share to Fas Ligand Protein
Share to Genotyping Techniques

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunotherapy

Share to Neoplasm Recurrence, Local

Share to Polymerase Chain Reaction

Share to Polymorphism, Single Nucleotide

Share to Urinary Bladder Neoplasms

Source

Identifiers

PMID: 29453645
DOI: 10.1007/s11845-018-1764-7

Genes

FAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Emphasis of FAS/FASL gene polymorphism in patients with non-muscle invasive bladder cancer.PMID 29453645Read ↗

FASL polymorphism is associated with response to bacillus Calmette-Guérin immunotherapy in bladder cancer.Semantic proximity Read ↗

The role of functional polymorphisms in immune response genes as biomarkers of bacille Calmette-Guérin (BCG) immunotherapy outcome in bladder cancer: establishment of a predictive profile in a Southern Europe population.Semantic proximity Read ↗

The Roles of miRNAs in Predicting Bladder Cancer Recurrence and Resistance to TreatmentSemantic proximity Read ↗

Functional genetic variants in apoptosis-associated FAS and FASL genes and risk of bladder cancer in a Turkish population.Semantic proximity Read ↗

HLA class-I genotyping to personalize Bacille Calmette-Guerin immunotherapy in bladder cancer.Semantic proximity Read ↗

Functional polymorphisms in the promoter regions of the FAS and FAS ligand genes and risk of bladder cancer in south China: a case-control analysis.Semantic proximity Read ↗

GSTT1 as a prognosticator for recurrence and progression in patients with non-muscle-invasive bladder cancer.Semantic proximity Read ↗

Differential Role of NKG2A/Hla-E Interaction in the Outcome of Bladder Cancer Patients Treated with M. bovis Bcg or Other TherapiesSemantic proximity Read ↗

GSTM1 tissue genotype as a recurrence predictor in non-muscle invasive bladder cancer.Semantic proximity Read ↗

The Role of Vitamin D Receptor Polymorphisms in Predicting the Response to Therapy for Nonmuscle Invasive Bladder Carcinoma.Semantic proximity Read ↗

Novel approaches in the management of bladder cancerSemantic proximity Read ↗

Polymorphisms in inflammation genes and bladder cancer: from initiation to recurrence, progression, and survival.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.